278 related articles for article (PubMed ID: 18381102)
1. Antibody and immunomodulatory agents in the treatment of indolent non-Hodgkin's lymphoma.
LaCasce AS; Freedman AS
Semin Hematol; 2008 Apr; 45(2):85-9. PubMed ID: 18381102
[TBL] [Abstract][Full Text] [Related]
2. Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphoma.
Friedberg JW; Freedman AS
Curr Treat Options Oncol; 2006 Jul; 7(4):276-84. PubMed ID: 16916488
[TBL] [Abstract][Full Text] [Related]
3. Combination treatment approaches and novel therapies for lymphoma.
Leonard JP; Friedberg JW; Hagemeister FB; Levine AM
Clin Adv Hematol Oncol; 2007 Aug; 5(8 Suppl 12):4-20; quiz 1 p following 20. PubMed ID: 18154235
[No Abstract] [Full Text] [Related]
4. Immunotherapy for non-Hodgkin's lymphoma: monoclonal antibodies and vaccines.
Maloney DG
J Clin Oncol; 2005 Sep; 23(26):6421-8. PubMed ID: 16155029
[TBL] [Abstract][Full Text] [Related]
5. Antibody therapy for non-Hodgkin's lymphoma.
Ansell SM
Curr Opin Mol Ther; 2004 Apr; 6(2):175-81. PubMed ID: 15195930
[TBL] [Abstract][Full Text] [Related]
6. Novel and engineered anti-B-cell monoclonal antibodies for non-Hodgkin's lymphoma.
Martin P; Furman RR; Ruan J; Elstrom R; Barrientos J; Niesvizky R; Coleman M; Leonard JP
Semin Hematol; 2008 Apr; 45(2):126-32. PubMed ID: 18381108
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the treatment of patients with rituximab-pretreated recurrent indolent non-Hodgkin lymphoma.
Leonard JP; Gregory SA; Maloney DG; Vose JM; Younes A; Zelenetz AD
Clin Adv Hematol Oncol; 2008 Jun; 6(6):437-45. PubMed ID: 18567989
[TBL] [Abstract][Full Text] [Related]
8. A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatment.
Prodanovic EM; Korman NJ
J Dermatolog Treat; 2008; 19(6):1-3. PubMed ID: 18720187
[TBL] [Abstract][Full Text] [Related]
9. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.
Maeda LS; Advani RH
Curr Opin Oncol; 2009 Sep; 21(5):397-400. PubMed ID: 19606035
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy and antibody combinations for relapsed/refractory non-Hodgkin's lymphoma.
Halwani AS; Link BK
Expert Rev Anticancer Ther; 2011 Mar; 11(3):443-55. PubMed ID: 21417857
[TBL] [Abstract][Full Text] [Related]
11. Elevation of activated platelet-dependent chemokines in patients with anti-CD20 monoclonal antibody (rituximab)-treated non-Hodgkin's lymphoma.
Nomura S; Ishii K; Kamitsuji Y; Uoshima N; Ishikawa E; Kitayama H; Hayashi K
Clin Appl Thromb Hemost; 2007 Apr; 13(2):206-12. PubMed ID: 17456632
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic idiotype vaccines for non-Hodgkin's lymphoma.
Timmerman JM
Adv Pharmacol; 2004; 51():271-93. PubMed ID: 15464914
[No Abstract] [Full Text] [Related]
13. Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: regulators of growth fraction and programmed cell death.
Winter JN
Semin Oncol; 1999 Oct; 26(5 Suppl 14):26-33. PubMed ID: 10561015
[TBL] [Abstract][Full Text] [Related]
14. Use of rituximab in combination with conventional chemotherapy for the treatment of non-Hodgkin's lymphoma of the head and neck.
Manolopoulos L; Gomatos IP; Leandros E; Alevizos L; Georgiou N; Giotakis J; Ferekidis E
In Vivo; 2009; 23(3):475-8. PubMed ID: 19454517
[TBL] [Abstract][Full Text] [Related]
15. Antibody-targeted therapy for low-grade lymphoma.
Vose JM
Semin Hematol; 1999 Oct; 36(4 Suppl 6):15-20. PubMed ID: 10530712
[TBL] [Abstract][Full Text] [Related]
16. Vaccines in lymphoma.
Levy R
Clin Adv Hematol Oncol; 2004 Jul; 2(7):424, 427. PubMed ID: 16163215
[No Abstract] [Full Text] [Related]
17. Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL.
Schmidt HH; Renner H; Linkesch W
Haematologica; 2004 Nov; 89(11):ECR39. PubMed ID: 15533844
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody therapy of cancer.
Weiner LM
Semin Oncol; 1999 Oct; 26(5 Suppl 14):43-51. PubMed ID: 10561017
[TBL] [Abstract][Full Text] [Related]
19. Emerging treatments for indolent lymphoma.
Cheson BD; Gregory SA; Marcus R
Clin Adv Hematol Oncol; 2007 May; 5(5 Suppl 8):1-9; quiz 11-2. PubMed ID: 17637594
[TBL] [Abstract][Full Text] [Related]
20. Personalized immunotherapy for the treatment of non-Hodgkin's lymphoma: a promising approach.
Vose JM
Hematol Oncol; 2006 Jun; 24(2):47-55. PubMed ID: 16447298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]